• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡型甲状腺癌的临床行为:表现和生存。

Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

出版信息

Laryngoscope. 2010 Apr;120(4):712-6. doi: 10.1002/lary.20828.

DOI:10.1002/lary.20828
PMID:20205241
Abstract

OBJECTIVES/HYPOTHESIS: To determine the prevalence and extent of disease characteristics of the follicular variant of papillary thyroid carcinoma (FV-PTC) and the survival impact of this histopathological diagnosis compared to classical papillary thyroid carcinoma (C-PTC).

STUDY DESIGN

Cross-sectional population analysis of a national cancer database.

METHODS

Cases of C-PTC and FV-PTC were extracted from the Surveillance, Epidemiology and End Results database for 1988 to 2006 and staged. Surgical extent and radioactive iodine (RAI) use were determined. Demographic and staging parameters were statistically compared according to tumor histology. Survival differences according to histology were determined with a Cox proportional hazards model, adjusting for age, sex, T stage, N stage, surgical therapy, and RAI.

RESULTS

A total of 46,699 patients were identified (68.4% C-PTC and 31.6% FV-PTC). Age at presentation and sex distribution were similar between FV-PTC (47.9 years; 79.3% female) and C-PTC patients (46.2 years; 77.3% female). Although nodal disease prevalence was significantly lower in FV-PTC compared to C-PTC (14.8% vs. 27.8%, respectively; P < .001), T stage was not significantly different (P = .450). Mean overall survivals for patients with FV-PTC (204.5 months) and C-PTC (205.3 months) were not significantly different (P = .373). Cox regression analysis revealed that advanced age (P < .001), male sex (P < .001), advanced T stage (P < .001), and positive nodal disease (P < .001) were associated with reduced overall survival, whereas histopathological subtype was not (P = .360).

CONCLUSIONS

Disease presentation (with exception of nodal metastasis) and survival in patients with FV-PTC are statistically similar to that of C-PTC, and accordingly these patients carry very similar prognoses.

摘要

目的/假设:确定滤泡型甲状腺乳头状癌(FV-PTC)的疾病特征的患病率和程度,以及与经典型甲状腺乳头状癌(C-PTC)相比,这种组织病理学诊断对生存的影响。

研究设计

对国家癌症数据库进行的横断面人群分析。

方法

从 1988 年至 2006 年的监测、流行病学和最终结果数据库中提取 C-PTC 和 FV-PTC 病例,并对其进行分期。确定手术范围和放射性碘(RAI)的使用。根据肿瘤组织学,对人口统计学和分期参数进行统计学比较。使用 Cox 比例风险模型确定组织学差异的生存差异,调整年龄、性别、T 分期、N 分期、手术治疗和 RAI。

结果

共确定了 46699 例患者(68.4%为 C-PTC,31.6%为 FV-PTC)。FV-PTC(47.9 岁;79.3%为女性)和 C-PTC 患者的发病年龄和性别分布相似(46.2 岁;77.3%为女性)。尽管 FV-PTC 患者的淋巴结疾病患病率明显低于 C-PTC(分别为 14.8%和 27.8%;P<.001),但 T 分期无显著差异(P=0.450)。FV-PTC(204.5 个月)和 C-PTC(205.3 个月)患者的总生存率无显著差异(P=0.373)。Cox 回归分析显示,年龄较大(P<.001)、男性(P<.001)、较高的 T 分期(P<.001)和阳性淋巴结疾病(P<.001)与总生存时间缩短相关,而组织病理学亚型无关(P=0.360)。

结论

FV-PTC 患者的疾病表现(除淋巴结转移外)和生存与 C-PTC 统计学上相似,因此这些患者具有非常相似的预后。

相似文献

1
Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.滤泡型甲状腺癌的临床行为:表现和生存。
Laryngoscope. 2010 Apr;120(4):712-6. doi: 10.1002/lary.20828.
2
Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.滤泡型甲状腺乳头状癌的临床行为:表现和生存。
Laryngoscope. 2010;120 Suppl 4:S163. doi: 10.1002/lary.21627.
3
Population-based outcomes for pediatric thyroid carcinoma.儿童甲状腺癌的基于人群的结局
Laryngoscope. 2005 Feb;115(2):337-40. doi: 10.1097/01.mlg.0000154743.71184.09.
4
Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.侵袭性甲状腺乳头状癌的变异型:43738 例患者中的发病率、特征和生存预测因素。
Ann Surg Oncol. 2012 Jun;19(6):1874-80. doi: 10.1245/s10434-011-2129-x. Epub 2011 Nov 8.
5
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.希腊 1991 年至 2006 年间甲状腺切除术患者甲状腺乳头状癌检出率增高。
Anticancer Res. 2009 Dec;29(12):5163-9.
6
Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.甲状腺乳头状癌的纯型与滤泡变体:临床特征、预后因素、治疗及生存情况
Cancer. 2003 Mar 1;97(5):1181-5. doi: 10.1002/cncr.11175.
7
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.甲状腺乳头状癌的乳头状和滤泡状变体:初始表现及对治疗的反应
Otolaryngol Head Neck Surg. 2005 Jun;132(6):840-4. doi: 10.1016/j.otohns.2005.02.002.
8
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
9
A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.基于人群的分化型和髓样甲状腺癌生存因素分析。
Otolaryngol Head Neck Surg. 2003 Jan;128(1):115-23. doi: 10.1067/mhn.2003.2.
10
High recurrent rate of multicentric papillary thyroid carcinoma.多中心性乳头状甲状腺癌的高复发率。
Ann Surg Oncol. 2009 Sep;16(9):2609-16. doi: 10.1245/s10434-009-0565-7. Epub 2009 Jun 16.

引用本文的文献

1
Beyond Surgical Limits: A Case Report of Follicular Variant of Papillary Thyroid Carcinoma With Persistent Disease Despite Aggressive Surgical Management.超越手术极限:一例滤泡型乳头状甲状腺癌病例报告,尽管采取了积极的手术治疗仍存在持续性疾病
Cureus. 2025 Apr 9;17(4):e81978. doi: 10.7759/cureus.81978. eCollection 2025 Apr.
2
Radioactive iodine therapy may not improve disease-specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score-matched analysis.放射性碘治疗可能无法提高无远处转移滤泡状甲状腺癌患者的疾病特异性生存率:一项倾向评分匹配分析。
Head Neck. 2021 Jun;43(6):1730-1738. doi: 10.1002/hed.26637. Epub 2021 Feb 9.
3
Diagnostic pitfalls and therapeutic outcomes of the macrofollicular variant of papillary thyroid carcinoma.
甲状腺大滤泡型乳头状癌的诊断陷阱与治疗结局。
Biomed J. 2019 Feb;42(1):59-65. doi: 10.1016/j.bj.2018.12.006. Epub 2019 Mar 20.
4
Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features.评估将非侵袭性包裹性滤泡型甲状腺乳头状癌重新分类为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤对手术的预期影响。
Surgery. 2018 Jan;163(1):60-65. doi: 10.1016/j.surg.2017.04.037. Epub 2017 Nov 13.
5
An Update on the Risk of Lymph Node Metastasis for the Follicular Variant of Papillary Thyroid Carcinoma with the New Diagnostic Paradigm.基于新诊断模式的甲状腺乳头状癌滤泡变体淋巴结转移风险的最新情况
Head Neck Pathol. 2018 Mar;12(1):105-109. doi: 10.1007/s12105-017-0835-9. Epub 2017 Jun 24.
6
Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density.甲状腺乳头状癌和髓样癌中的淋巴结转移与瘤内淋巴管密度无关。
Eur Thyroid J. 2017 Apr;6(2):57-64. doi: 10.1159/000457794. Epub 2017 Mar 17.
7
Sonographic differences between conventional and follicular variant papillary thyroid carcinoma.传统型与滤泡变体型甲状腺乳头状癌的超声差异
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2907-2913. doi: 10.1007/s00405-017-4557-0. Epub 2017 Apr 10.
8
Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.比较甲状腺乳头状癌的TT-UMP、经典型和非包膜滤泡型变体之间的临床病理及影像学表现
Endocr Pathol. 2016 Sep;27(3):233-42. doi: 10.1007/s12022-016-9437-4.
9
Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?甲状腺乳头状癌滤泡变体:混合性还是混合型?
Thyroid. 2016 Jul;26(7):872-4. doi: 10.1089/thy.2016.0244. Epub 2016 Jun 22.
10
Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer.菲律宾分化型甲状腺癌患者复发的风险因素。
Endocrinol Metab (Seoul). 2015 Dec;30(4):543-50. doi: 10.3803/EnM.2015.30.4.543. Epub 2015 Oct 20.